Pirogov Russian National Research Medical University is a medical higher education institution in Moscow, Russia founded in 1906. It is fully accredited and recognized by Russia's Ministry of Education and Science and is currently under the authority of the Ministry of Health and Social Development.

During the past decade, Russian State Medical University conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Russian State Medical University" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "ActivBiotics" with 1 trials sponsored, "Bausch Health Americas, Inc." with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Russian State Medical University" #1 collaborator was "Bayer" with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Russian State Medical University" are "HBV" (2 trials), "Bipolar Depression" (1 trials), "Chronic HBV Infection" (1 trials), "Chronic HIV Infection" (1 trials) and "Chronic Hepatitis C" (1 trials). Many other conditions were trialed in "Russian State Medical University" in a lesser frequency.

Most popular intervention types in "Russian State Medical University" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "TAF" (2 trials), "TAF Placebo" (2 trials), "TDF" (2 trials), "TDF Placebo" (2 trials) and "Alemtuzumab 12 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Russian State Medical University" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Russian State Medical University". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Russian State Medical University, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Russian State Medical University, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Russian State Medical University has several departments that took part in Clinical trials: "SEI HPE Moscow Medical Academy IM Sechenov of Roszdrav Clinic of Endocrinology" - 3 trials, "Russian Scientific Center of Restoration Medicine & Balneology" - 2 trials, "Department of Faculty Surgery №1" - 2 trials, "Moscow State Medical Dentistry University" - 2 trials, "Pulmonology Research Institute" - 2 trials